General Guidelines in the Management of an Obstetrical Patient on the Labor and Delivery Unit during the COVID-19 Pandemic

 

 Permissions and Reprints

Abstract

Novel coronavirus disease 2019 (COVID-19) is a respiratory tract infection that was first identified in China. Since its emergence in December 2019, the virus has rapidly spread, transcending geographic barriers. The World Health Organization and the Centers for Disease Control and Prevention have declared COVID-19 as a public health crisis. Data regarding COVID-19 in pregnancy is limited, consisting of case reports and small cohort studies. However, obstetric patients are not immune from the current COVID-19 pandemic, and obstetric care will inevitably be impacted by the current epidemic. As such, clinical protocols and practice on labor and delivery units must adapt to optimize the safety of patients and health care workers and to better conserve health care resources. In this commentary, we provide suggestions to meet these goals without impacting maternal or neonatal outcomes.

Key Points

• Novel coronavirus disease 2019 (COVID-19) is a pandemic.

• COVID-19 impacts care of obstetric patients.

• Health care should be adapted for the COVID-19 pandemic.

• References

• 1 Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol 2020 (e-pub ahead of print) Doi: 10.1016/j.ajog.2020.02.017
  PubMedGoogle Scholar
• 2 Zhu H, Wang L, Fang C. , et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020; 9 (01) 51-60
  CrossrefPubMedGoogle Scholar
• 3 World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Available at: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected . Accessed April 14, 2020
  PubMedGoogle Scholar
• 4 Liang H, Acharya G. Novel corona virus disease (COVID-19) in pregnancy: what clinical recommendations to follow?. Acta Obstet Gynecol Scand 2020; 99 (04) 439-442
  CrossrefPubMedGoogle Scholar
• 5 Chen D, Yang H, Cao Y. , et al. Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection. Int J Gynaecol Obstet 2020; 149 (02) 130-136
  CrossrefPubMedGoogle Scholar
• 6 Chen H, Guo J, Wang C. , et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395 (10226): 809-815
  CrossrefPubMedGoogle Scholar
• 7 Chen S, Huang B, Luo DJ. , et al. [Pregnant women with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases] (in Chinese). Zhonghua Bing Li Xue Za Zhi 2020; 49 (00) E005 (e-pub ahead of print)
  PubMedGoogle Scholar
• 8 Jiao J. Under the epidemic situation of COVID-19, should special attention to pregnant women be given?. J Med Virol 2020 (e-pub ahead of print) Doi: 10.1002/jmv.25771
  PubMedGoogle Scholar
• 9 Poon LC, Yang H, Lee JCS. , et al. ISUOG interim guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol 2020 Doi: 10.1002/uog.22013
  PubMedGoogle Scholar
• 10 Schwartz DA. An Analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med 2020 (e-pub ahead of print) Doi: 10.5858/arpa.2020-0901-SA
  PubMedGoogle Scholar
• 11 Schwartz DA, Graham AL. Potential maternal and infant outcomes from (Wuhan) Coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and Other human coronavirus infections. Viruses 2020; 12 (02) 194
  CrossrefPubMedGoogle Scholar
• 12 Liu D, Li L, Wu X. , et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol 2020 (e-pub ahead of print) Doi: 10.2214/AJR.20.23072 :1–6
  PubMedGoogle Scholar
• 13 Liu Y, Chen H, Tang K, Guo Y. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect 2020 (e-pub ahead of print) Doi: 10.1016/j.jinf.2020.02.028
  PubMedGoogle Scholar
• 14 Liu H, Liu F, Li J, Zhang T, Wang D, Lan W. Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children. J Infect 2020 (e-pub ahead of print) Doi: 10.1016/j.jinf.2020.03.007
  PubMedGoogle Scholar
• 15 Mullins E, Evans D, Viner RM, O'Brien P, Morris E. Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol 2020 (e-pub ahead of print) Doi: 10.1002/uog.22014
  PubMedGoogle Scholar
• 16 Panahi L, Amiri M, Pouy S. Risks of novel coronavirus disease (COVID-19) in pregnancy; a narrative review. Arch Acad Emerg Med 2020; 8 (01) e34
  PubMedGoogle Scholar
• 17 Zeng L, Xia S, Yuan W. , et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr 2020 (e-pub ahead of print) Doi: 10.1001/jamapediatrics.2020.0878
  PubMedGoogle Scholar
• 18 Zeng H, Xu C, Fan J. , et al. Antibodies in infants born to mothers with COVID-19 pneumonia. JAMA 2020 (e-pub ahead of print) Doi: 10.1001/jama.2020.4861
  PubMedGoogle Scholar
• 19 Fan C, Lei D, Fang C. , et al. Perinatal transmission of COVID-19 associated SARS-CoV-2: should we worry?. Clin Infect Dis 2020 (e-pub ahead of print) Doi: 10.1093/cid/ciaa226
  PubMedGoogle Scholar
• 20 Stower H. Lack of maternal-fetal SARS-CoV-2 transmission. Nat Med 2020; 26 (03) 312
  PubMedGoogle Scholar
• 21 Qiao J. What are the risks of COVID-19 infection in pregnant women?. Lancet 2020; 395 (10226): 760-762
  CrossrefPubMedGoogle Scholar
• 22 Centers for Disease Control. Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Finfection-control%2Fcontrol-recommendations.html . Accessed April 14, 2020
  PubMedGoogle Scholar
• 23 Society for Maternal Fetal Medicine and Society for Obstetric and Anesthesia and Perinatology. Labor and Delivery COVID-19 Considerations. Available at: https://s3.amazonaws.com/cdn.smfm.org/media/2277/SMFM-SOAP_COVID_LD_Considerations_3-27-20_(final)_PDF.pdf . Accessed April 1, 2020
  PubMedGoogle Scholar
• 24 Rosenbaum RA, Benyo JS, O'Connor RE. , et al. Use of a portable forced air system to convert existing hospital space into a mass casualty isolation area. Ann Emerg Med 2004; 44 (06) 628-634
  CrossrefPubMedGoogle Scholar
• 25 Bischoff W, Russell G, Willard E, Stehle Jr J. Impact of a novel mobile high-efficiency particulate air-ultraviolet air recirculation system on the bacterial air burden during routine care. Am J Infect Control 2019; 47 (08) 1025-1027
  CrossrefPubMedGoogle Scholar
• 26 Oren I, Haddad N, Finkelstein R, Rowe JM. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Am J Hematol 2001; 66 (04) 257-262
  CrossrefPubMedGoogle Scholar
• 27 Poston JT, Patel BK, Davis AM. Management of critically ill adults with COVID-19. JAMA 2020 (e-pub ahead of print) Doi: 10.1001/jama.2020.4914
  PubMedGoogle Scholar
• 28 Grobman WA, Rice MM, Reddy UM. , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med 2018; 379 (06) 513-523
  CrossrefPubMedGoogle Scholar
• 29 Barton JR, Sibai BM. Severe sepsis and septic shock in pregnancy. Obstet Gynecol 2012; 120 (03) 689-706
  CrossrefPubMedGoogle Scholar
• 30 Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin no. 188: prelabor rupture of membranes. Obstet Gynecol 2018; 131 (01) e1-e14
  CrossrefPubMedGoogle Scholar
• 31 Morris JM, Roberts CL, Bowen JR. , et al; PPROMT Collaboration. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet 2016; 387 (10017): 444-452
  CrossrefPubMedGoogle Scholar
• 32 Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003; 101 (01) 178-193
  PubMedGoogle Scholar
• 33 Peaceman AM, Lai Y, Rouse DJ. , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Length of latency with preterm premature rupture of membranes before 32 weeks' gestation. Am J Perinatol 2015; 32 (01) 57-62
  PubMedGoogle Scholar
• 34 Rouse DJ, Hirtz DG, Thom E. , et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359 (09) 895-905
  CrossrefPubMedGoogle Scholar
• 35 Pasquier JC, Claris O, Rabilloud M. , et al. Intentional early delivery versus expectant management for preterm premature rupture of membranes at 28-32 weeks' gestation: a multicentre randomized controlled trial (MICADO STUDY). Eur J Obstet Gynecol Reprod Biol 2019; 233: 30-37
  CrossrefPubMedGoogle Scholar
• 36 Cox SM, Leveno KJ. Intentional delivery versus expectant management with preterm ruptured membranes at 30-34 weeks' gestation. Obstet Gynecol 1995; 86 (06) 875-879
  CrossrefPubMedGoogle Scholar
• 37 Caughey AB, Cahill AG, Guise JM, Rouse DJ. ; American College of Obstetricians and Gynecologists (College); Society for Maternal-Fetal Medicine. Safe prevention of the primary cesarean delivery. Am J Obstet Gynecol 2014; 210 (03) 179-193
  CrossrefPubMedGoogle Scholar
• 38 Hui DS, Ip M, Tang JW. , et al. Airflows around oxygen masks: A potential source of infection?. Chest 2006; 130 (03) 822-826
  CrossrefPubMedGoogle Scholar
• 39 Hui DS, Hall S, Chan MT, Joynt GM, Chow B, Sung JJ. Risks posed by the use of oxygen therapy and non-invasive positive pressure ventilation: a pilot study. Hong Kong Med J 2009; 15 (Suppl. 08) 4-7
  PubMedGoogle Scholar
• 40 Somogyi R, Vesely AE, Azami T. , et al. Dispersal of respiratory droplets with open vs closed oxygen delivery masks: implications for the transmission of severe acute respiratory syndrome. Chest 2004; 125 (03) 1155-1157
  CrossrefPubMedGoogle Scholar
• 41 Ankumah NE, Blackwell SC, Alrais MA. , et al. Liberal versus indicated maternal oxygen supplementation in labor: a before-and-after Trial. Am J Perinatol 2018; 35 (11) 1057-1064
  Article in Thieme ConnectPubMedGoogle Scholar
• 42 Jozwik M, Sledziewski A, Klubowicz Z, Zak J, Sajewska G, Pietrzycki B. [Use of oxygen therapy during labour and acid-base status in the newborn] (in Polish). Med Wieku Rozwoj 2000; 4 (04) 403-411
  PubMedGoogle Scholar
• 43 Nesterenko TH, Acun C, Mohamed MA. , et al. Is it a safe practice to administer oxygen during uncomplicated delivery: a randomized controlled trial?. Early Hum Dev 2012; 88 (08) 677-681
  CrossrefPubMedGoogle Scholar
• 44 Qian G, Xu X, Chen L. , et al. The effect of maternal low flow oxygen administration during the second stage of labour on umbilical cord artery pH: a randomised controlled trial. BJOG 2017; 124 (04) 678-685
  CrossrefPubMedGoogle Scholar
• 45 Thorp JA, Trobough T, Evans R, Hedrick J, Yeast JD. The effect of maternal oxygen administration during the second stage of labor on umbilical cord blood gas values: a randomized controlled prospective trial. Am J Obstet Gynecol 1995; 172 (2, Pt 1): 465-474
  CrossrefPubMedGoogle Scholar
• 46 American College of Obstetricians and Gynecologists; Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 127: management of preterm labor. Obstet Gynecol 2012; 119 (06) 1308-1317
  CrossrefPubMedGoogle Scholar
• 47 Dixon CL, Too G, Saade GR, Gyamfi-Bannerman C. Past and present: a review of antenatal corticosteroids and recommendations for late preterm birth steroids. Am J Perinatol 2018; 35 (13) 1241-1250
  Article in Thieme ConnectPubMedGoogle Scholar
• 48 Gyamfi-Bannerman C, Thom EA, Blackwell SC. , et al; NICHD Maternal–Fetal Medicine Units Network. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med 2016; 374 (14) 1311-1320
  CrossrefPubMedGoogle Scholar
• 49 Kamath-Rayne BD, Rozance PJ, Goldenberg RL, Jobe AH. Antenatal corticosteroids beyond 34 weeks gestation: what do we do now?. Am J Obstet Gynecol 2016; 215 (04) 423-430
  CrossrefPubMedGoogle Scholar
• 50 Porto AM, Coutinho IC, Correia JB, Amorim MM. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial. BMJ 2011; 342: d1696
  CrossrefPubMedGoogle Scholar
• 51 Yinon Y, Haas J, Mazaki-Tovi S. , et al. Should patients with documented fetal lung immaturity after 34 weeks of gestation be treated with steroids?. Am J Obstet Gynecol 2012; 207 (03) 222.e1-222.e4
  CrossrefPubMedGoogle Scholar
• 52 Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS. ; Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 2006; 367 (9526): 1913-1919
  CrossrefPubMedGoogle Scholar
• 53 Garite TJ, Kurtzman J, Maurel K, Clark R. ; Obstetrix Collaborative Research Network. Impact of a ‘rescue course’ of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. Am J Obstet Gynecol 2009; 200 (03) 248.e1-248.e9
  CrossrefPubMedGoogle Scholar
• 54 Lee MJ, Davies J, Guinn D. , et al. Single versus weekly courses of antenatal corticosteroids in preterm premature rupture of membranes. Obstet Gynecol 2004; 103 (02) 274-281
  CrossrefPubMedGoogle Scholar
• 55 McEvoy C, Bowling S, Williamson K. , et al. The effect of a single remote course versus weekly courses of antenatal corticosteroids on functional residual capacity in preterm infants: a randomized trial. Pediatrics 2002; 110 (2, Pt 1): 280-284
  CrossrefPubMedGoogle Scholar
• 56 Murphy KE, Hannah ME, Willan AR. , et al; MACS Collaborative Group. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet 2008; 372 (9656): 2143-2151
  CrossrefPubMedGoogle Scholar
• 57 Wapner RJ, Sorokin Y, Thom EA. , et al; National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol 2006; 195 (03) 633-642
  CrossrefPubMedGoogle Scholar
• 58 American College of Obstetricians and Gynecologists. ACOG Practice Bulletin no. 202: gestational hypertension and preeclampsia. Obstet Gynecol 2019; 133 (01) e1-e25
  PubMedGoogle Scholar
• 59 American College of Obstetricians and Gynecologists and Society of Maternal Fetal Medicine. Committee opinion no 652: magnesium sulfate use in obstetrics. Obstet Gynecol 2016; 127 (01) e52-e53
  Google Scholar
• 60 Altman D, Carroli G, Duley L. , et al; Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 359 (9321): 1877-1890
  CrossrefPubMedGoogle Scholar
• 61 Little P. Non-steroidal anti-inflammatory drugs and covid-19. BMJ 2020; 368: m1185
  PubMedGoogle Scholar
• 62 Russell B, Moss C, George G. , et al. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience 2020; 14: 1022
  PubMedGoogle Scholar
• 63 Voiriot G, Philippot Q, Elabbadi A, Elbim C, Chalumeau M, Fartoukh M. Risks related to the use of non-steroidal anti-inflammatory drugs in community-acquired pneumonia in adult and pediatric patients. J Clin Med 2019; 8 (06) E786
  CrossrefPubMedGoogle Scholar
• 64 FitzGerald GA. Misguided drug advice for COVID-19. Science 2020; 367 (6485): 1434
  PubMedGoogle Scholar
• 65 Varrassi G. Warning against the use of anti-inflammatory medicines to cure COVID-19: building castles in the air. Adv Ther 2020 (e-pub ahead of print) Doi: 10.1007/s12325-020-01321-1
  PubMedGoogle Scholar
• 66 Amici C, Di Caro A, Ciucci A. , et al. Indomethacin has a potent antiviral activity against SARS coronavirus. Antivir Ther 2006; 11 (08) 1021-1030
  PubMedGoogle Scholar
• 67 Committee on Practice Bulletins-Obstetrics. Practice bulletin no. 183: postpartum hemorrhage. Obstet Gynecol 2017; 130 (04) e168-e186
  CrossrefPubMedGoogle Scholar